Safety First: Fractional Nonablative Laser Resurfacing in Fitzpatrick Skin Types IV to VIApril 15, 2013AcneAesthetic DermatologyPigmentation Disorders
Cosmetic Corner: Dermatologists Weigh in on OTC Acne PreparationsMarch 1, 2013AcneAesthetic Dermatology
Clindamycin Phosphate 1.2%–Benzoyl Peroxide (5% or 2.5%) Plus Tazarotene Cream 0.1% for the Treatment of AcneFebruary 1, 2013Acne
A Dermatologist's Dilemma: Treatment Failure or Failure to Treat? [editorial]November 1, 2012Aesthetic DermatologyAcne
Phototoxic and Photoallergic Potential of Tazarotene Foam 0.1% in 2 Phase 1 Patch StudiesNovember 1, 2012AcneContact DermatitisAesthetic Dermatology
Cumulative Irritation Potential and Contact Sensitization Potential of Tazarotene Foam 0.1% in 2 Phase 1 Patch StudiesOctober 1, 2012AcneContact Dermatitis
Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors: Treatment With Oral IsotretinoinAugust 1, 2012Acne
Randomized, Observer-Blind, Split-Face Study to Compare the Irritation Potential of 2 Topical Acne Formulations Over a 14-Day Treatment PeriodAugust 1, 2012Acne
